Want to see FR:LTA full AI Analyst Report?
ALTAMIR (LTA) Stock Price & Analysis
LTA Stock Chart & Stats
- Day’s Range
- EUR 21.60 - EUR 22.30
- 52-Week Range
- EUR 21.60 - EUR 30.80
- Previous Close
- EUR 22.20
- Volume
- N/A
- Average Volume (3M)
- 385
- Market Cap
- EUR 788.67M
- Enterprise Value
- EUR 903.53M
- Total Cash (Recent Filing)
- EUR 16.55M
- Total Debt (Recent Filing)
- EUR 88.40M
- Price to Earnings (P/E)
- 51.4
- Beta
- -0.00
- Next Earnings
- Mar 18, 2027 (Est.)
- EPS Estimate
- N/A
- Last Dividend Ex-Date
- Sep 26, 2025
- Dividend Yield
- 4.91%
Bulls Say, Bears Say
Bulls Say
Strong Equity Base And Low Leverage
A large equity base and zero reported debt provide financial resilience and reduce balance-sheet pressure. This gives Altamir greater flexibility to manage portfolio outcomes, absorb volatility, and continue supporting its investment strategy without significant interest or refinancing burdens.
Diversified Private Equity Platform
The diversified private equity model spreads exposure across regions, sectors, and investment structures rather than relying on one company or market. This breadth can support portfolio resilience and create multiple avenues for value creation over the medium term.
Demonstrated 2024 Profitability And Growth
The 2024 results show that Altamir has demonstrated the ability to generate strong profitability and growth in a favorable portfolio realization environment. That performance provides evidence of underlying earnings potential, even though subsequent results were substantially weaker.
Bears Say
Severe Latest-Year Earnings Reversal
The sharp move from meaningful 2024 profitability to a large 2025 loss materially weakens earnings visibility. If results remain this volatile, it becomes harder to assess sustainable performance, plan capital allocation, or rely on reported earnings as a consistent measure of value creation.
Unstable Cash Generation
Cash generation has not followed a stable or repeatable pattern, with several years of negative operating and free cash flow followed by a sharp 2025 decline. This inconsistency can constrain internally funded investment and makes the company’s cash resources less predictable over time.
Inconsistent Profitability And Returns
Repeated swings in profitability and returns on equity reduce confidence in the durability of Altamir’s earnings quality. Even with a strong equity base, persistent or recurring losses could pressure book value and make medium-term portfolio performance more difficult to evaluate.
LTA FAQ
What was ALTAMIR’s price range in the past 12 months?
What is ALTAMIR’s market cap?
When is ALTAMIR’s upcoming earnings report date?
How were ALTAMIR’s earnings last quarter?
Is ALTAMIR overvalued?
Does ALTAMIR pay dividends?
What is ALTAMIR’s EPS estimate?
How many shares outstanding does ALTAMIR have?
What happened to ALTAMIR’s price movement after its last earnings report?
Which hedge fund is a major shareholder of ALTAMIR?
What is the TipRanks Smart Score and how is it calculated?
Company Description
ALTAMIR
Altamir SCA, previously known as Altamir Amboise, is a Paris-based private equity firm established in 1995. The company employs a dual investment strategy, engaging in both direct investments and fund-of-funds, primarily targeting small and mid-cap companies. For its direct investments, Altamir concentrates on the middle market, executing buyout and growth capital transactions, and shows a particular interest in acquiring underdeveloped segments of larger corporate entities. When investing through other funds, the firm prioritizes private equity funds that specialize in growth capital and leveraged buyouts, often seeking a majority or lead shareholder position within these investments. Its sector focus is broad, encompassing healthcare, technology (including TMT and digital enterprises), various services, retail and distribution, consumer goods, and business and financial services. Within healthcare, Altamir specifically seeks out high-growth potential companies across health services (such as hospitalization, home care, and medical analysis), medical devices, niche pharmaceutical laboratories, and related areas like dermo-cosmetics, galenic development, and services/databases for health organizations. Geographically, Altamir targets unlisted companies across Europe, with a keen focus on Belgium, France, Luxembourg, Switzerland, Monaco, Italy, the Netherlands, Germany, and French-speaking European regions. It also extends its reach to North America (United States and Canada) and major emerging economies including China, India, and Brazil. For smaller and mid-sized companies, the firm prefers Continental Europe, particularly France, Italy, and the Benelux countries, while larger companies are sought across Europe, North America, and the aforementioned emerging markets. Investment sizes range from an enterprise value of €50 million to €500 million for small to mid-cap entities, and €500 million to €3,000 million for larger enterprises. Altamir makes balance sheet investments and frequently collaborates with Apax Partners France and Amboise Investissement, investing and divesting alongside them under identical terms. Furthermore, it directly invests in funds managed or advised by Apax Partners France and Apax Partners LLC. The firm typically aims for an investment horizon of five years before exiting.
- Sector
- General
- Industry
- Asset Management
- CEO
- Maurice Tchenio
- Employees
- 0
- Website
- www.altamir.fr
- Address
- 1 rue Paul Cézanne, Paris, IF, 75008, FR
ALTAMIR (LTA) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 6 | 2 | 14 |
| Technical Analysis | 6 | 2 | 2 |
| Moving Averages | 0 | 0 | 12 |
